Fragment-to-Lead Medicinal Chemistry Publications in 2021
Journal of Medicinal Chemistry · 2023
DOI: 10.1021/acs.jmedchem.2c01827 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Medicinal Chemistry, 2023. Verfasst von Louise Walsh und 5 weiteren Autor:innen. Beteiligte Einrichtung: Astex Pharmaceuticals, 436 Cambridge Science Park, Milton Road, Cambridge CB4 0QA, United Kingdom. Hauptthemen laut MEDLINE: Chemistry, Pharmaceutical, Drug Discovery. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 73 Literaturangaben.
Abstract (Originalsprache)
This Perspective is the seventh in an annual series that summarizes successful Fragment-to-Lead (F2L) case studies published in a given year. A tabulated summary of relevant articles published in 2021 is provided, and features such as target class, screening methods, and ligand efficiency are discussed, both for the 2021 examples and for the combined examples over the years 2015-2021. In addition, trends and new developments in the field are summarized. In particular, the use of structural information in fragment-based drug discovery is discussed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Astex Pharmaceuticals, 436 Cambridge Science Park, Milton Road, Cambridge CB4 0QA, United Kingdom.
- Frontier Medicines, 151 Oyster Point Blvd., South San Francisco, California 94080, United States.
- Division of Medicinal Chemistry, Amsterdam Institute for Molecules, Medicines and Systems (AIMMS), Vrije Universiteit Amsterdam, De Boelelaan 1108, 1081 HZ Amsterdam, The Netherlands.
- Chemical Biology and Therapeutics, Novartis Institutes for Biomedical Research, 4002 Basel, Switzerland.
ORCID-Profile: Louise Walsh, Daniel A Erlanson, Iwan J P de Esch, Wolfgang Jahnke
Zitieren
APA
Walsh, L., Erlanson, D. A., de Esch, I. J. P., Jahnke, W., Woodhead, A., & Wren, E. (2023). Fragment-to-Lead Medicinal Chemistry Publications in 2021. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.2c01827
Vancouver
Walsh L, Erlanson DA, de Esch IJP, Jahnke W, Woodhead A, Wren E. Fragment-to-Lead Medicinal Chemistry Publications in 2021. Journal of Medicinal Chemistry. 2023. doi:10.1021/acs.jmedchem.2c01827
BibTeX
@article{Walsh2023,
author = {Walsh, Louise and Erlanson, Daniel A and de Esch, Iwan J P and Jahnke, Wolfgang and Woodhead, Andrew and Wren, Ella},
title = {Fragment-to-Lead Medicinal Chemistry Publications in 2021},
journal = {Journal of Medicinal Chemistry},
year = {2023},
doi = {10.1021/acs.jmedchem.2c01827}
}
EUVIMED